Beiersdorf (BEI GY) H1 2026 (EUR): Revenue 4.95bln (exp. 4.96bln)

• "Starting from 2028, the company expects to return to profitable growth with net sales growth above market and steady EBIT margin improvement."

FY26 Guidance: cut, amid the continued difficult market environment and a slower than expected NIVEA recovery.

• Organic sales lower by low-single digit % (prev. guided flat to slight growth)
• Consumer Business EBIT >11% (prev. 13.6%, prev. guided just below Y/Y)

Guidance cuts of this kind in European staples tend to be received more harshly than the underlying print, because the downgrade, not the in-line half, is what reprices the full-year consensus that anchors the multiple. The distinction worth drawing here is between a demand problem and a brand-specific problem: the company attributes the cut partly to a slower NIVEA recovery, which points to execution and brand investment rather than purely to the category backdrop, and that distinction determines how much of the shortfall peers will be read across into. The Consumer Business EBIT margin reset, from guidance of just below prior-year levels to a materially lower absolute figure, is the sharper element, since margin trajectory rather than organic sales has been the market's focus for this peer set. Management pushing the return to above-market growth out to a multi-year horizon is a familiar sequence in these episodes: credibility of the deferred target becomes the debate, and the stock typically trades on whether investors treat the reset as clearing or as the first of several. Worth watching are the peer prints in European personal care for evidence of category-wide softness versus company-specific slippage, and any commentary on promotional intensity and pricing in the mass skincare channel.